ArticleAnnals of surgical oncology2016

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

Melissa Pilewskie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.